{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:45:35Z","timestamp":1785350735726,"version":"3.55.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7232322"],"award-info":[{"award-number":["7232322"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Little is known about autoimmune hepatitis (AIH) in Chinese children. The study aimed to explore the clinical characteristics and predictors of outcomes in the Chinese paediatric AIH cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review of all paediatric AIH cases from 2015 to 2025 was conducted at a single centre in Beijing, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 50 enrolled cases, 39 (78.0%) presented with type 1 AIH (consisting of 30 female children (60.0%); median age of 9.2\u202fyears). At presentation, 24 (48.0%) patients had cirrhosis, 11 (22.0%) had liver failure, and 10 (20.0%) had decompensated cirrhosis at presentation. Compared to type 1, children with type 2 were younger and had higher levels of serum alanine aminotransferase [270.0 (166.0, 599.0) U\/L vs. 610.0 (510.0, 1231.0) U\/L,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.003] and aspartate aminotransferase [335.0 (172.0, 756.0) U\/L vs. 576.0 (433.0, 1020.0) U\/L,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.013]; however, there was no statistical significance in the outcome between the two groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;gt;\u202f0.05). In 48 cases that received initial immunosuppressive treatment (glucocorticoid alone\u202f=\u202f18, in combination with azathioprine\u202f=\u202f20, or with mycophenolate mofetil\u202f=\u202f10), 41 (85.4%) patients survived with a native liver, and there was no statistical difference in prognosis among the three types of immunosuppressive treatments. Serum albumin levels and decompensated cirrhosis at presentation were identified as independent factors influencing the likelihood of death or the need for liver transplantation (OR 0.814 [95% CI 0.670\u20130.989],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.039; OR 0.146 [95% CI 0.022\u20130.963],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.046).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The majority of paediatric AIH patients survive with a native liver, and the outcome is not related to the type of immunosuppressive therapies but to decompensated cirrhosis at presentation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1733006","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:14:35Z","timestamp":1768205675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical characteristics and outcomes in 50 children with autoimmune hepatitis: a retrospective study from a single centre in China"],"prefix":"10.3389","volume":"12","author":[{"given":"Yandi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zherui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binxia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuna","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengsheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"EASL clinical practice guidelines on the management of autoimmune hepatitis","volume":"83","author":"Dalekos","year":"2025","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20\u2013year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jhep.2023.02.017","article-title":"Paediatric autoimmune hepatitis: time to change the textbooks?","volume":"78","author":"Lohse","year":"2023","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"102280","DOI":"10.1016\/j.eclinm.2023.102280","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970\u20132022: a systematic review and meta-analysis","volume":"65","author":"Hahn","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1875-9572(09)60035-8","article-title":"Emerging importance of autoimmune hepatitis in children in Taiwan, an endemic area for viral hepatitis","volume":"50","author":"Yeh","year":"2009","journal-title":"Pediatrics Neonatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e0182391","DOI":"10.1371\/journal.pone.0182391","article-title":"Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea","volume":"12","author":"Yu","year":"2017","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"982186","DOI":"10.3389\/fimmu.2022.982186","article-title":"Metabolic heterogeneity caused by HLA-DRB1*04:05 and protective effect of inosine on autoimmune hepatitis","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/hep.31893","article-title":"Human leukocyte antigen profile predicts severity of autoimmune liver disease in children of European ancestry","volume":"74","author":"Ma","year":"2021","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/MPG.0000000000003538","article-title":"Expression of HLA and autoimmune pathway genes in Liver biopsies of young subjects with autoimmune hepatitis type 1","volume":"75","author":"Shin","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"103436","DOI":"10.1016\/j.jaut.2025.103436","article-title":"HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives","volume":"154","author":"Wang","year":"2025","journal-title":"J Autoimmun"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/MPG.0000000000001930","article-title":"Autoimmune hepatitis in children and adolescents","volume":"66","author":"Trevizoli","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jhep.2023.01.013","article-title":"Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood","volume":"78","author":"Maggiore","year":"2023","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/liv.14280","article-title":"Permanent immunosuppression in SLA\/LP-positive autoimmune hepatitis is required although overall response and survival are similar","volume":"40","author":"Zachou","year":"2019","journal-title":"Liver Int"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/MCG.0b013e318228b781","article-title":"The impact of race\/ethnicity on the clinical epidemiology of autoimmune hepatitis","volume":"46","author":"Wong","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1002\/hep.31985","article-title":"We are not immune: racial and ethnic disparities in autoimmune Liver diseases","volume":"74","author":"Lee","year":"2021","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e1237","DOI":"10.1542\/peds.2015-0578","article-title":"Incidence and characteristics of autoimmune hepatitis","volume":"136","author":"Jim\u00e9nez-Rivera","year":"2015","journal-title":"Pediatrics"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"114635","DOI":"10.1016\/j.jpeds.2025.114635","article-title":"Various regimens for autoimmune hepatitis in northern European children show equivalent outcomes at 1 year: a retrospective study","volume":"284","author":"J\u00f8rgensen","year":"2025","journal-title":"J Pediatr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3760\/cma.j.issn.0578-1310.2010.10.010","article-title":"Clinical characteristics of autoimmune hepatitis in 11 children","volume":"48","author":"Lu","year":"2010","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3760\/cma.j.issn.0578-1310.2019.01.010","article-title":"Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis","volume":"57","author":"Cao","year":"2019","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S1542-3565(04)00354-4","article-title":"Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody","volume":"2","author":"Bridoux\u2014henno","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","article-title":"Update of the simplified criteria for autoimmune hepatitis: evaluation of the methodology for immunoserological testing","volume":"74","author":"Galaski","year":"2021","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and Management of Autoimmune Hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"101496","DOI":"10.1016\/j.jhepr.2025.101496","article-title":"Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapy","volume":"7","author":"Chen","year":"2025","journal-title":"JHEP Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e41378","DOI":"10.1097\/MD.0000000000041378","article-title":"Immunosuppressive treatment in autoimmune decompensated cirrhosis, when to say enough: a retrospective analysis","volume":"104","author":"Barbero","year":"2025","journal-title":"Medicine"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/MPG.0000000000003268","article-title":"North American Society for Pediatric Gastroenterology, hepatology, and nutrition position paper on the diagnosis and management of pediatric acute liver failure","volume":"74","author":"Squires","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/hepr.13776","article-title":"Clinical practice guidelines for autoimmune hepatitis","volume":"52","author":"Ohira","year":"2022","journal-title":"Hepatol Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the international autoimmune hepatitis group","volume":"76","author":"Pape","year":"2022","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/jgh.14746","article-title":"Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population","volume":"34","author":"Lv","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12072-014-9558-0","article-title":"Characteristics and outcome of autoimmune liver disease in Asian children","volume":"9","author":"Lee","year":"2014","journal-title":"Hepatol Int"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1377333","DOI":"10.3389\/fped.2024.1377333","article-title":"The etiology and differential diagnosis of \u201cautoimmune hepatitis-like liver disease\u201d in children: a single-center retrospective study","volume":"12","author":"Ma","year":"2024","journal-title":"Front Pediatr"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"60933","DOI":"10.18632\/oncotarget.17458","article-title":"Association of STAT4 and PTPN22 polymorphisms and their interactions with type-1 autoimmune hepatitis susceptibility in Chinese Han children","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/hepr.12998","article-title":"Clinical features of pediatric autoimmune hepatitis in Japan: a nationwide survey","volume":"48","author":"Sogo","year":"2017","journal-title":"Hepatol Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.11622\/smedj.2014179","article-title":"Childhood autoimmune hepatitis in a paediatric unit of a tertiary care hospital","volume":"55","author":"Low","year":"2014","journal-title":"Singapore Med J"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1097\/MPG.0000000000002050","article-title":"Spectrum of pediatric autoimmune Liver disease and validation of its diagnostic scores in Indian children","volume":"67","author":"Sood","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/apt.12592","article-title":"Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis","volume":"39","author":"Czaja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1136\/gutjnl-2024-333171","article-title":"British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis","volume":"74","author":"Gleeson","year":"2025","journal-title":"Gut"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/0016-5085(95)90215-5","article-title":"High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis","volume":"108","author":"Targan","year":"1995","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12016-021-08888-9","article-title":"Autoimmune hepatitis: serum autoantibodies in clinical practice","volume":"63","author":"Terziroli Beretta-Piccoli","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/MPG.0000000000003513","article-title":"Long-term growth in children and young people with autoimmune Liver disease treated with daily steroids","volume":"75","author":"Manwani","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","article-title":"Autoimmmune hepatitis","volume":"19","author":"Terziroli Beretta-Piccoli","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","article-title":"Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials","volume":"53","author":"Lamers","year":"2010","journal-title":"J Hepatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"100601","DOI":"10.1016\/j.jhepr.2022.100601","article-title":"Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis","volume":"4","author":"Dalekos","year":"2022","journal-title":"JHEP Reports"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A single center review of the use of mycophenolate Mofetil in the treatment of autoimmune hepatitis","volume":"6","author":"Hlivko","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1053216","DOI":"10.3389\/fimmu.2022.1053216","article-title":"Standard immunosuppressive treatment reduces regulatory B cells in children with autoimmune liver disease","volume":"13","author":"Yuksel","year":"2023","journal-title":"Front Immunol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/liv.15943","article-title":"Outcomes and management in paediatric autoimmune hepatitis presenting as acute liver failure: individual patient data meta-analysis","volume":"44","author":"Fawzy","year":"2024","journal-title":"Liver Int"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/cld.797","article-title":"Long-term outcomes of autoimmune hepatitis","volume":"14","author":"Gleeson","year":"2019","journal-title":"Clinical Liver Disease"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1053\/jhep.2002.32485","article-title":"Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis","volume":"35","author":"Czaja","year":"2002","journal-title":"Hepatology"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1733006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:14:38Z","timestamp":1768205678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1733006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":49,"alternative-id":["10.3389\/fmed.2025.1733006"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1733006","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1733006"}}